These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24836404)

  • 1. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics.
    Singhal K; Kaushik N; Kumar A
    Curr Drug Deliv; 2022; 19(6):644-657. PubMed ID: 34238187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cubic-to-inverted micellar and the cubic-to-hexagonal-to-micellar transitions on phytantriol-based cubosomes induced by solvents.
    Lotierzo MCG; Casadei BR; de Castro RD; Malheiros B; Barbosa LRS
    Drug Deliv Transl Res; 2020 Dec; 10(6):1571-1583. PubMed ID: 32783155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
    Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
    J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cubosome: A Potential Liquid Crystalline Carrier System.
    Sharma P; Dhawan S; Nanda S
    Curr Pharm Des; 2020; 26(27):3300-3316. PubMed ID: 32552637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
    Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
    Micron; 2007; 38(5):478-85. PubMed ID: 17011783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Insight into Cubosomal Drug Delivery Approaches: An Explicative Review.
    Mukherjee S; Dutta A; Ash D; Karati D
    Pharm Nanotechnol; 2024 Jun; ():. PubMed ID: 38910488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple-by-design approach for production of stabilizer-free cubosomes from phosphatidylglycerol and docosahexaenoic acid monoacylglycerol.
    Kalaycioglu GD; Bor G; Yaghmur A
    J Colloid Interface Sci; 2024 Dec; 675():825-835. PubMed ID: 39002233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
    Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
    J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
    Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
    AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel design for stable self-assembly cubosome precursor-microparticles enhancing dissolution of insoluble drugs.
    Mei L; Xie Y; Jing H; Huang Y; Chen J; Ran H; Pan X; Wu C
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1239-1243. PubMed ID: 28276277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cubosomes: Innovative Nanostructures for Drug Delivery.
    Duttagupta AS; Chaudhary HM; Jadhav KR; Kadam VJ
    Curr Drug Deliv; 2016; 13(4):482-93. PubMed ID: 25707403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
    Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
    Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, Characterization, and Antimicrobial Activity of Cubosome Encapsulated Metal Nanocrystals.
    Meikle TG; Dyett BP; Strachan JB; White J; Drummond CJ; Conn CE
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6944-6954. PubMed ID: 31917545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of Cubosomes with Improved Colloidal and Structural Stability Using a Gemini Surfactant.
    Nagao M; Ranneh AH; Iwao Y; Yamamoto K; Ikeda Y
    Mol Pharm; 2023 Oct; 20(10):5066-5077. PubMed ID: 37726201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System.
    Garg M; Goyal A; Kumari S
    Curr Drug Metab; 2021; 22(6):441-450. PubMed ID: 33402079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.